Variable
Tigecycline-induced pancreatitis (n = 21) Non-pancreatitis (n = 3720)
P value
Age (years), median (IQR) 48.0 (36.5–58.5) 54.0 (44.0–65.0) .072*
Sex (male), n (%) 15 (71.4) 2538 (68.2) .753
Length of stay (days), median (IQR) 30.0 (25.0–43.5) 25.0 (17.0–37.0) .024*
Hypertension, n (%) 6 (28.6) 811 (21.8) .454
Coronary heart disease, n (%) 3 (14.3) 224 (6.0) .114
Diabetes mellitus, n (%) 1 (4.8) 428 (11.5) .333
Chronic obstructive pulmonary disease, n (%) 0 (0) 140 (3.8) .365
Bronchial asthma, n (%) 0 (0) 9 (2.8) .821
Renal insufficiency, n (%) 7 (33.3) 579 (15.6) .025*
Liver insufficiency, n (%) 3 (14.3) 911 (24.5) .278
Solid organ tumor, n (%) 2 (9.5) 537 (14.4) .523
Autoimmune disease, n (%) 0 (0) 98 (2.6) .451